Octahydropyrrolo[2, 3, c]pyridine derivatives and pharmaceutical use thereof

Details for Australian Patent Application No. 2005263762 (hide)

International Classifications

Event Publications

25 January 2007 PCT application entered the National Phase

PCT publication WO2006/008303 Priority application(s): WO2006/008303

25 October 2007 Assignment before Grant

Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

30 April 2009 Alteration of Name

The name of the applicant has been altered to Merck Serono SA

25 August 2011 Application Accepted

Published as AU-B-2005263762

3 November 2011 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 22 Sep 2011. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

1 March 2012 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 22 Sep 2011

1 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.